The MM+M editorial team was heartened by the progress made treating Alzheimer’s disease, the case of KJ Muldoon and ...

The lack of gains in productivity from AI could stall adoption and burst the economic bubble. Is there a rational explanation ...

A new evaluation of artificial intelligence systems suggests that while modern language models are becoming more capable at logical reasoning, they struggle significantly to distinguish between ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...

The Student Affairs Mentoring Program and Leadership Experience (SAMPLE) is designed for undergraduate students who are interested in higher education and student affairs. Through this program, which ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

This study presents a valuable advance in reconstructing naturalistic speech from intracranial ECoG data using a dual-pathway model. The evidence supporting the claims of the authors is solid, ...